全文获取类型
收费全文 | 305835篇 |
免费 | 15458篇 |
国内免费 | 680篇 |
专业分类
耳鼻咽喉 | 3945篇 |
儿科学 | 9733篇 |
妇产科学 | 6833篇 |
基础医学 | 43795篇 |
口腔科学 | 7471篇 |
临床医学 | 23585篇 |
内科学 | 69014篇 |
皮肤病学 | 8799篇 |
神经病学 | 27218篇 |
特种医学 | 8668篇 |
外国民族医学 | 131篇 |
外科学 | 38263篇 |
综合类 | 1395篇 |
一般理论 | 80篇 |
预防医学 | 27855篇 |
眼科学 | 5781篇 |
药学 | 21208篇 |
中国医学 | 981篇 |
肿瘤学 | 17218篇 |
出版年
2023年 | 1679篇 |
2022年 | 2278篇 |
2021年 | 5878篇 |
2020年 | 3253篇 |
2019年 | 5921篇 |
2018年 | 9382篇 |
2017年 | 6160篇 |
2016年 | 6238篇 |
2015年 | 6904篇 |
2014年 | 8194篇 |
2013年 | 12431篇 |
2012年 | 20287篇 |
2011年 | 20509篇 |
2010年 | 10641篇 |
2009年 | 8763篇 |
2008年 | 17239篇 |
2007年 | 18337篇 |
2006年 | 17086篇 |
2005年 | 17079篇 |
2004年 | 15803篇 |
2003年 | 14631篇 |
2002年 | 13883篇 |
2001年 | 8286篇 |
2000年 | 8369篇 |
1999年 | 7365篇 |
1998年 | 1734篇 |
1997年 | 1381篇 |
1996年 | 1250篇 |
1995年 | 1131篇 |
1992年 | 3999篇 |
1991年 | 3649篇 |
1990年 | 3447篇 |
1989年 | 3065篇 |
1988年 | 2872篇 |
1987年 | 2718篇 |
1986年 | 2578篇 |
1985年 | 2356篇 |
1984年 | 1744篇 |
1983年 | 1470篇 |
1979年 | 1504篇 |
1978年 | 1056篇 |
1977年 | 962篇 |
1975年 | 1038篇 |
1974年 | 1236篇 |
1973年 | 1241篇 |
1972年 | 1168篇 |
1971年 | 1152篇 |
1970年 | 1098篇 |
1969年 | 1126篇 |
1968年 | 987篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
92.
93.
94.
95.
Susan C. Fox Jane A. May Natalia Dovlatova Jackie R. Glenn Andrew Johnson Ann E. White 《Platelets》2019,30(3):290-295
Measurement of P-selectin on activated platelets as a means of measuring platelet function utilizing the technology described here has the advantage of not requiring immediate access to specialist equipment and expertise. Blood samples are activated, fixed, stored, and transported to a central laboratory for flow cytometric analysis. Here we have compared P-selectin with other more traditional approaches to measuring platelet function in blood and/or platelet-rich plasma (PRP) from patients with acute coronary syndromes on treatment for at least 1 month with either aspirin and clopidogrel or aspirin with prasugrel. The comparators were light transmission aggregometry (LTA), VerifyNow and Multiplate aggregometry (for determining the effects of aspirin) and LTA, VerifyNow and Multiplate together with the BioCytex VASP phosphorylation assay (for the P2Y12 antagonists). The P-selectin Aspirin Test revealed substantial inhibition of platelet function in all but three of 96 patients receiving aspirin with clopidogrel and in none of 51 patients receiving aspirin and prasugrel. The results were very similar to those obtained using LTA. There was only one patient with high residual platelet aggregation and low P-selectin expression. The same patients identified as “non-responders” to aspirin also presented with the highest residual platelet activity as measured using the VerifyNow system, although not quite as well separated from the other values. With the Multiplate test only one of these patients clearly stood out from the others. The results obtained using the P-selectin P2Y12 Test in 102 patients taking aspirin and clopidogrel were similar to the more traditional approaches in that a wide scatter of results was obtained. Generally, high values seen with the P-selectin P2Y12 Test were also high with the LTA, VerifyNow, Multiplate, and BioCytex VASP P2Y12 Tests. Similarly, low residual platelet function using the P2Y12 test was seen irrespective of the testing procedure used. However, there were differences in some patients. Prasugrel was always more effective than clopidogrel in inhibiting platelet function with none of 56 patients (P-selectin and VerifyNow), only 2 of 56 patients (Multiplate) and only 3 of 56 patients (Biocytex VASP) demonstrating high on-treatment residual platelet reactivity (HRPR) defined using previously published cut-off values. The exception was LTA where there were 11 of 56 patients with HRPR. It remains to be seen which experimental approach provides the most useful information regarding outcomes after adjusting therapies in treated patients. 相似文献
96.
97.
José M. Martín M.D. Ph.D. Gerardo Beteta M.D. Andrea Allende M.D. Esperanza Jordá M.D. Ph.D. 《Pediatric dermatology》2015,32(6):e303-e304
We report on a 3‐year‐old girl with a microvesicular generalized rash in whom primary infection by parvovirus B19 was demonstrated by seroconversion. To our knowledge, this is the first instance of an eruption arising from parvovirus B19 with this peculiar clinical pattern. 相似文献
98.
Miguel A. Sanz Pau Montesinos Haesook T. Kim Guillermo J. Ruiz-Argüelles María S. Undurraga María R. Uriarte Lem Martínez Rafael H. Jacomo Homero Gutiérrez-Aguirre Raul A. M. Melo Rosane Bittencourt Ricardo Pasquini Katia Pagnano Evandro M. Fagundes Edo Vellenga Alexandra Holowiecka Ana J. González-Huerta Pascual Fernández Javier De la Serna Salut Brunet Elena De Lisa José González-Campos José M. Ribera Isabel Krsnik Arnold Ganser Nancy Berliner Raul C. Ribeiro Francesco Lo-Coco Bob L?wenberg Eduardo M. Rego 《Annals of hematology》2015,94(8):1347-1356
99.
A. Guerrero Gómez N. González Jaramillo J.A. Castro Pérez 《Revista espa?ola de anestesiología y reanimación》2019,66(1):10-17
Introduction
The fast track / ultra-fast-track protocols are techniques used to optimise the patient care process and a quick recovery after cardiac surgery. They are one of the mainstays of efficient practice. With their use, the length of hospital and intensive care unit (ICU) stays are reduced, with a direct impact on costs and the quality of the health service.Objective
To compare the length of stay in the ICU, length of hospital stay, and post-operative mortality in ultra-fast-track extubated (uFTE) patients and those with conventional extubation (CE) after cardiac surgery.Methods
Longitudinal, analytical, retrospective study was conducted, with the period between the time of surgery and discharge being included as the study period.Results
A total of 396 patients older than 18 years who required cardiac surgery were included, of whom 207 patients had (uFTE) and 189 had CE. Although the groups were not comparable due to the statistical differences found, when performing the multivariate adjustment, uFTE maintained its statistical independence and was associated with lower cardiovascular morbidity, such as myocardial ischaemia (95% CI: 0.37-0.86; P = .01) and lower post-surgical vasopressor requirement (95% CI: 0.18-0.49; P < .01). No significant differences were found in the length of hospital stay, ICU stay, or post-operative mortality in the ICU.Conclusion
Implementing the uFTE strategy, decreases cardiovascular morbidity and vasopressor requirement. The change to uFTE should be accompanied by changes in models and practices in patient recovery to standardised protocols. This study shows that uFTE did not reduce the length of ICU stay, hospital stay, or mortality. 相似文献100.
Oliver Sartor MD Daniel Heinrich MD Neil Mariados MD Maria José Méndez Vidal MD Daniel Keizman MD Camilla Thellenberg Karlsson MD Avivit Peer MD Giuseppe Procopio MD Stephen J. Frank MD Kalevi Pulkkanen MD Eli Rosenbaum MD Stefano Severi MD José Trigo MD Lucia Trandafir MD Volker Wagner MD Rui Li MS Luke T. Nordquist MD 《The Prostate》2019,79(14):1683-1691